Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Campbell Bradley L Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 11,200 shares @ $11.2027, valued at $125.5k
Sold 500 shares @ $12.038, valued at $6k
Exercised 11,700 options to buy @ $2.94, valued at $34.4k
10/02/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 20,000 shares @ $13.3937, valued at $267.9k
Exercised 11,700 options to buy @ $2.94, valued at $34.4k
08/01/2023 144 Form 144 - Report of proposed sale of securities:
07/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/12/2023 144 Form 144 - Report of proposed sale of securities:
07/06/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 11,700 shares @ $12.3091, valued at $144k
Exercised 11,700 options to buy @ $2.94, valued at $34.4k
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/08/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 8,300 shares @ $12.5032, valued at $103.8k
06/06/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 11,700 shares @ $11.3626, valued at $132.9k
Exercised 7,125 options to buy @ $2.45, valued at $17.5k
Exercised 4,575 options to buy @ $2.94, valued at $13.5k
06/01/2023 144 Form 144 - Report of proposed sale of securities:
05/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/01/2023 144 Form 144 - Report of proposed sale of securities:
04/05/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 11,700 shares @ $11.2143, valued at $131.2k
Exercised 11,700 options to buy @ $2.45, valued at $28.7k
03/17/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 13,375 shares @ $11.43, valued at $152.9k
02/03/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 20,000 shares @ $12.9754, valued at $259.5k
Exercised 11,700 options to buy @ $2.45, valued at $28.7k
01/13/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 98,040 shares @ $0
Paid exercise price by delivering 50,147 shares @ $12.02, valued at $602.8k
01/11/2023 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 11,700 shares @ $11.432, valued at $133.8k
Exercised 11,700 options to buy @ $2.45, valued at $28.7k
01/06/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2022 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 5,470 shares @ $10.5346, valued at $57.6k
Exercised 5,470 options to buy @ $3.53, valued at $19.3k
09/06/2022 4 Campbell Bradley L (President & CEO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 5,470 shares @ $11.2914, valued at $61.8k
Exercised 5,470 options to buy @ $3.53, valued at $19.3k
08/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/08/2022 4 Campbell Bradley L (COO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 104,603 shares @ $0
Granted 187,970 options to buy @ $8.95, valued at $1.7M
03/22/2022 4 Campbell Bradley L (COO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 10,940 shares @ $10.0024, valued at $109.4k
Exercised 10,940 options to buy @ $3.53, valued at $38.6k
01/19/2022 4 Campbell Bradley L (COO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Granted 63,317 shares @ $0
Paid exercise price by delivering 32,386 shares @ $10.53, valued at $341k
01/04/2022 4 Campbell Bradley L (COO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 17,597 shares @ $11.55, valued at $203.2k
Paid exercise price by delivering 27,946 shares @ $11.55, valued at $322.8k
Paid exercise price by delivering 4,984 shares @ $12.11, valued at $60.4k
Sold 5,470 shares @ $11.8611, valued at $64.9k
Granted 154,711 shares @ $0
Paid exercise price by delivering 7,368 shares @ $12.48, valued at $92k
Exercised 5,470 options to buy @ $3.53, valued at $19.3k
Granted 283,555 options to buy @ $12.11, valued at $3.4M
12/23/2021 4 Campbell Bradley L (COO) has filed a Form 4 on AMICUS THERAPEUTICS, INC.
Txns: Sold 3,000 shares @ $11.6985, valued at $35.1k
Exercised 3,000 options to buy @ $4.38, valued at $13.1k
12/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy